Format Follows Function: Media Considerations for Future-Proofing AAV Manufacturing Processes

Published on: 

Sponsored Content

Although the potential of gene therapy has been established for decades, it is only in recent years that the industry has seen a major turning point with the first therapies receiving approval in the late 2010s. As the potential of these therapies is realized, the question of the hour is: how do we manufacture AAV gene therapies sustainably in the long term?